Stay updated on ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial

Sign up to get notified when there's something new on the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number for the ClinicalTrials.gov interface was updated from v3.5.2 to v3.5.3. This reflects a system update rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-25T18:31:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:21:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The References and Oversight sections were removed from the study record page, reducing access to cited sources and governance details.
    Difference
    0.2%
    Check dated 2026-04-11T10:29:05.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-20T19:58:29.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:08:01.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 is added to the record history, replacing the prior v3.4.1 entry.
    Difference
    0.1%
    Check dated 2026-02-13T12:53:28.000Z thumbnail image

Stay in the know with updates to ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page.